VERTIGO DIAGNOSIS & TREATMENT SYSTEM

Precision in every position.

An integrated platform for binocular eye movement capture, Benign Paroxysmal Positional Vertigo (BPPV) assessment, controlled three-dimensional repositioning and structured clinical documentation.

DiagnosisTreatmentData
YBL-VDTS BPPV diagnosis and treatment system
Product familyYBL-VDTS I / II
Integrated platformAssess. Treat. Document.
3DFully automated 3D movement
180°/sX-axis maximum speed
360°/sY-axis maximum speed
220 VPower supply
VNGBinocular nystagmus recording
THE SYSTEM

A more repeatable path from assessment to repositioning.

The YBL-VDTS series brings mechanics, electronics, image processing and protocol-guided treatment into one purpose-built system for benign paroxysmal positional vertigo.

Preset motion parameters guide the patient through controlled three-dimensional positioning, while the VNG module captures nystagmus data to support clinical decision-making.

CONNECTED CLINICAL WORKFLOW

One system. One continuous record.

Closely coordinated acquisition, analysis and motion-control modules help clinicians move through each stage with clarity.

01

Capture

Record binocular eye movement data in real time with the integrated VNG system.

02

Assess

Review nystagmus patterns and quantitative data to support BPPV classification.

03

Reposition

Apply controlled three-dimensional positioning with configurable treatment protocols.

04

Document

Store examinations, videos, curves and treatment results for review and research.

ENGINEERED FOR PRECISION

Technology that moves care forward.

Purpose-built mechanical design and intelligent control create a stable platform for precise positioning and efficient deployment.

3D

Coordinated motion control

Three-axis coordinated movement supports precise, repeatable 360-degree positioning.

MOD

Modular architecture

A segmented frame is designed for easier transport, installation and clinical deployment.

DRV

High-precision drive

A cycloidal drive design supports stable operation, load capacity and positioning accuracy.

AL

Lightweight

Aerospace-grade materials reduce system weight and expand installation possibilities.

SAFETY BY DESIGN

Confidence for clinicians and patients.

Multiple mechanical, electrical and operational safeguards are integrated into the system to support controlled examinations and treatment.

  • 01 Main-axis self-locking and a manual safety lever
  • 02 Homing switch and multiple emergency-stop controls
  • 03 Ergonomic seat, head support and multi-point restraints
  • 04 Emergency and coordinated-protection functions in software
Detail view of the YBL-VDTS treatment chair and safety restraint system
CLINICAL VALUE

Built for care today and insight tomorrow.

Clinical application

One platform for the complete BPPV workflow

Designed for ENT, neurology and vestibular care settings where consistent positional assessment and treatment matter.

Research value

Structured, multimodal clinical data

Build a traceable record of examinations, eye movement videos, curves and treatment results for deeper analysis.

Operational value

Standardize care with confidence

Protocol-guided positioning helps teams deliver a more repeatable clinical process while reducing manual workload.

ABOUT UBALION

Focused on innovation for ENT specialty care.

Founded in Tianjin, China in 2023, Ubalion is a medical technology company focused on the research, development and innovation of devices for ENT specialty care. The company's product development spans vestibular and balance systems, hearing-function assessment and voice analysis.

By combining in-house engineering with international collaboration, Ubalion works across mechanics, electronics, imaging and clinical software to support more standardized, data-informed workflows.

PRODUCT REGULATORY NOTICE

Market authorization varies by jurisdiction.

This website is intended for general product information and professional business enquiries. It does not represent authorization to sell, supply or place the YBL-VDTS into clinical use in any market.

01
Product documentation

Contact our team for current product documentation and information relevant to your market.

02
Markets outside China

The product has not received medical-device marketing authorization outside China.

03
Availability and intended use

Availability, indications, configuration, labeling and permitted use are subject to applicable local requirements. The product is not offered for sale or clinical use where the required authorization has not been obtained.

PRODUCT & MARKET ENQUIRIES

Discuss the YBL-VDTS for your market.

Tell us about your professional, distribution, research or regulatory needs. Our team will follow up with product information and the current market-specific regulatory status.

For professional enquiries only. Do not submit patient records or health information. Ordinary enquiry correspondence is retained for up to 12 months after the last substantive contact. Privacy requests: info@ubalion.com.